Clinical Trial Update: Clinical Study of SPH3348 Tablets, a C-Met Inhibitor, in Patients with Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating SPH3348 tablets, a C-Met inhibitor, in patients with advanced solid tumors has completed. The update does not include efficacy or safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• SPH3348 Tablets (SPH3348)

Snippet

Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd | Conditions: Solid Tumor | Phase 1 | Status: COMPLETED